The protein made by the DYRK1B gene helps control how cells grow and how your body handles fat, sugar, and muscle development. If the DYRK1B gene does not work in the usual way, some people can develop a rare inherited pattern of weight gain around the waist, insulin resistance, high blood pressure, abnormal blood fats, and earlier heart disease. Most people with common weight or blood sugar problems do not have a variant in the DYRK1B gene, but in some families it can be an important cause.
What is a gene?
Genes are stretches of DNA that carry instructions cells use to make molecules or direct processes throughout the body. Some provide the blueprint for proteins, which are the parts of cells that do the work. Others are used mainly to regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medicines. For a deeper look at this topic, more information is available in the LearnHub.
Overview
DYRK1BGene function
What if the gene works
The DYRK1B gene provides instructions for a protein that helps control how cells grow, rest, and mature. It is active in several tissues, including muscle, and supports normal communication inside cells.
Risk
What if the gene does not work
Pathogenic variants in the DYRK1B gene can cause a rare inherited metabolic syndrome with central obesity, insulin resistance or diabetes, and high blood pressure. Milder or more severe variants may change when it starts and how strongly it affects you.
Treatment
What does that mean for your treatment
No treatment specific to pathogenic variants in the DYRK1B gene is currently established in clinical guidelines. Medication choices follow standard treatment for the person’s blood sugar, blood pressure, cholesterol, and weight, not for the DYRK1B variant itself. The DYRK1B gene is also being studied as a possible drug target in cancer and metabolic disease, but this has not changed routine care.
Conditions associated with DYRK1B
Gene function
What if the gene works
Many everyday cell tasks depend on well-timed internal signals. In your body, the DYRK1B gene supports processes that help cells respond to those signals, pace growth, and mature into specialized cells. This is part of what the DYRK1B gene does in your body every day.
The DYRK1B gene makes a protein kinase, a protein that adds small phosphate tags to other proteins. These tags help pass messages inside cells so activity can be adjusted at the right time.
Its protein helps control when cells remain in a quiet resting state and when they get ready for growth. This supports steady tissue upkeep and orderly day to day cell activity.
DYRK1B activity helps some immature cells move toward a more specialized role. That shift lets cells stop focusing on division and start carrying out their usual job in tissue.
It influences transcription factors (proteins that switch genes on or off). Through these control proteins, cells can fine tune which instructions are used in different situations.
What is a variant?
A genetic variant is a slight alteration in the DNA sequence within a gene. These changes are common and help shape normal differences among people, such as appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic diversity. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the DYRK1B gene can change the protein's shape, stability, or chemical signaling activity, so cells receive weaker or altered signals. How variants in the DYRK1B gene affect cell signaling can vary: some DNA changes leave partial activity, while more disruptive variants can sharply reduce activity, misdirect the protein inside the cell, or make it less stable. In families with DYRK1B-related metabolic syndrome, greater functional disruption may go along with earlier or more noticeable features.
How variants are linked to conditions
Pathogenic variants in the DYRK1B gene cause a rare inherited form of metabolic syndrome, so DYRK1B gene variants linked to metabolic syndrome usually involve a clear family pattern. People with this diagnosis may develop central weight gain, insulin resistance or type 2 diabetes, high blood pressure, and abnormal cholesterol or triglyceride levels. Some families also show earlier heart and blood vessel disease.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology and are common across the general population. Most do not directly affect health and instead reflect natural human diversity. In many genes, carrying a variant associated with a condition indicates a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broad, clear evidence on specific factors that change risk in a predictable way for DYRK1B-related health problems. In families with a harmful DYRK1B variant, the gene change itself can play a major role, while body weight, eating patterns, physical activity, and other inherited factors may still affect when metabolic problems show up and how severe they become.
Inheritance of DYRK1B variants
For people asking about the DYRK1B inheritance pattern, disease-causing variants in the DYRK1B gene are inherited in an autosomal dominant way. This means one changed copy of the gene is enough to be passed on and be linked to the condition. If a parent carries a DYRK1B variant, each child has a 50% chance of inheriting it. Mothers and fathers can both pass it on, and it can affect sons and daughters alike.
What does my DYRK1B result mean for my family?
For the DYRK1B-related condition that has been described, the pattern in families is usually dominant, which means close relatives such as a parent, brother, sister, or child may also carry the same gene change. In practice, each child of someone with a disease-causing DYRK1B variant has a 1 in 2, or 50%, chance of inheriting it. Family members who carry the variant may show different features or severity.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for DYRK1B variants usually uses a blood or saliva sample. A lab reads the DNA sequence in the DYRK1B gene, often as part of a gene panel or exome test, to look for changes linked to a person's symptoms or family history. Results can confirm a diagnosis or show that no relevant variant was found.
When should I consider getting a genetic test?
If several relatives across generations have had extra weight around the waist, high blood sugar or type 2 diabetes, high blood pressure, and abnormal cholesterol or triglycerides starting unusually early, testing for DYRK1B may be worth discussing. Testing can also make sense if a blood relative already has a harmful DYRK1B change.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals varies by the condition and by the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts on its target. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can affect a person’s response to medications. It examines patterns between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence either how strongly a drug works or how the body processes it. This information can support treatment decisions that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the DYRK1B gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or how well they work. If you have side effects, questions about a new prescription, or concerns about your health, it is best to speak with your doctor.
History
DYRK1B entered the scientific literature in the 1990s as researchers mapped a group of related genes called DYRK kinases. It was identified as the human relative of earlier genes studied in animals, which helped place it within a broader family of genes involved in cell signaling. Building on this early work, scientists uncovered more about the gene as sequencing methods improved and family based studies became more precise. In the 2010s, DYRK1B drew wider medical interest when rare inherited variants were linked to a form of abdominal obesity, type 2 diabetes, and high blood pressure seen in some families. Later studies also connected the gene to certain developmental pathways and to a few cancers, which expanded research interest. These historical steps shaped today’s understanding of DYRK1B in human genetics.